Mei‐Sze Chua

7.0k total citations · 2 hit papers
55 papers, 4.0k citations indexed

About

Mei‐Sze Chua is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mei‐Sze Chua has authored 55 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Mei‐Sze Chua's work include Cancer Mechanisms and Therapy (7 papers), Synthesis and biological activity (6 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). Mei‐Sze Chua is often cited by papers focused on Cancer Mechanisms and Therapy (7 papers), Synthesis and biological activity (6 papers) and Wnt/β-catenin signaling in development and cancer (6 papers). Mei‐Sze Chua collaborates with scholars based in United States, China and United Kingdom. Mei‐Sze Chua's co-authors include Samuel So, Tracey D. Bradshaw, Wei Wei, Minnie Sarwal, Malcolm F. G. Stevens, Oscar Salvatierra, Szu‐Chuan Hsieh, Thomas Satterwhite, Ian Hutchinson and Neeraja Kambham and has published in prestigious journals such as Nature, New England Journal of Medicine and Nature Communications.

In The Last Decade

Mei‐Sze Chua

55 papers receiving 3.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray Profiling

2003 547 citations Minnie Sarwal, Mei‐Sze Chua et al. profile →
A transfer-RNA-derived small RNA regulates ribosome biogenesis

2017 405 citations Hak Kyun Kim, Gabriele Fuchs et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mei‐Sze Chua United States	33	2.1k	698	682	585	438	55	4.0k
Timothy Madden United States	37	2.1k 1.0×	164 0.2×	714 1.0×	1.6k 2.8×	81 0.2×	108	4.8k
Raymond J. Hohl United States	40	2.3k 1.1×	416 0.6×	818 1.2×	1.5k 2.6×	25 0.1×	138	4.9k
Jill Kolesar United States	37	2.0k 1.0×	282 0.4×	620 0.9×	1.8k 3.0×	33 0.1×	192	4.3k
Paul Statkevich United States	35	1.6k 0.8×	163 0.2×	646 0.9×	2.1k 3.5×	55 0.1×	92	4.8k
Paul W. Manley Switzerland	50	3.4k 1.6×	1.2k 1.8×	337 0.5×	2.0k 3.4×	38 0.1×	153	10.6k
Jan H. Beumer United States	40	2.3k 1.1×	189 0.3×	489 0.7×	2.1k 3.6×	33 0.1×	234	4.8k
Joseph Ciccolini France	36	1.6k 0.8×	114 0.2×	677 1.0×	2.4k 4.1×	57 0.1×	196	4.5k
Grace K. Dy United States	37	2.3k 1.1×	178 0.3×	644 0.9×	2.3k 3.9×	23 0.1×	213	4.7k
M. E. Scheulen Germany	36	2.3k 1.1×	409 0.6×	734 1.1×	2.6k 4.5×	16 0.0×	178	5.5k
Daniel L. Dexter United States	35	2.0k 1.0×	497 0.7×	1.1k 1.6×	1.4k 2.3×	19 0.0×	86	4.0k

Countries citing papers authored by Mei‐Sze Chua

Since Specialization

Citations

This map shows the geographic impact of Mei‐Sze Chua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Sze Chua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Sze Chua more than expected).

Fields of papers citing papers by Mei‐Sze Chua

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Sze Chua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Sze Chua. The network helps show where Mei‐Sze Chua may publish in the future.

Co-authorship network of co-authors of Mei‐Sze Chua

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Sze Chua. A scholar is included among the top collaborators of Mei‐Sze Chua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Sze Chua. Mei‐Sze Chua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Mingdian, Ye Wei, Yi Liu, et al.. (2025). Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling. British Journal of Pharmacology. 182(22). 5517–5535. 1 indexed citations

Liu, Yi, David Lechuga‐Ballesteros, Mingdian Tan, et al.. (2024). Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice. International Journal of Nanomedicine. Volume 19. 2639–2653. 7 indexed citations

Ma, Li, Wei Wei, Yi Liu, et al.. (2023). Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma. Liver International. 43(12). 2794–2807. 1 indexed citations

Xing, Jing, Rama Shankar, Meehyun Ko, et al.. (2022). Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants. iScience. 25(10). 105068–105068. 1 indexed citations

Natarajan, Arutselvan, Hui Zhang, Ye Wei, et al.. (2021). A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts. Cancers. 13(16). 3977–3977. 19 indexed citations

Li, Haoran, et al.. (2020). Predictive value of preoperative and postoperative peripheral lymphocyte difference in hepatitis B virus‐related hepatocellular cancer patients: Based on the analysis of dynamic nomogram. Journal of Surgical Oncology. 122(8). 1553–1568. 5 indexed citations

Chen, Bin, Lana X. Garmire, Diego F. Calvisi, et al.. (2020). Publisher Correction: Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology. 2 indexed citations

Chen, Bin, Lana X. Garmire, Diego F. Calvisi, et al.. (2020). Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma. Nature Reviews Gastroenterology & Hepatology. 17(4). 238–251. 102 indexed citations

Zhang, Mao, Shihai Liu, Mei‐Sze Chua, et al.. (2019). SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway. Cell Death and Disease. 10(8). 612–612. 102 indexed citations

10.

Zhang, Mao, Mei‐Sze Chua, Jie Hu, et al.. (2019). <p>High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection</p>. Cancer Management and Research. Volume 11. 10623–10632. 1 indexed citations

11.

Chen, Bin, Li Ma, Harikrishna Paik, et al.. (2017). Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nature Communications. 8(1). 16022–16022. 140 indexed citations

12.

Kim, Hak Kyun, Gabriele Fuchs, Shengchun Wang, et al.. (2017). A transfer-RNA-derived small RNA regulates ribosome biogenesis. Nature. 552(7683). 57–62. 405 indexed citations breakdown →

13.

Chen, Bin, Wei Wei, Li Ma, et al.. (2017). Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. Gastroenterology. 152(8). 2022–2036. 69 indexed citations

14.

Lü, Wenjing, Mei‐Sze Chua, & Samuel So. (2013). Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis. 35(4). 915–922. 47 indexed citations

15.

Yen, Yi‐Fen, Mei‐Sze Chua, Lei Xing, et al.. (2010). In vivo MRSI of hyperpolarized [1‐¹³C]pyruvate metabolism in rat hepatocellular carcinoma. NMR in Biomedicine. 24(5). 506–513. 49 indexed citations

16.

Yan, Xinrui, Mei‐Sze Chua, Jing He, & Samuel So. (2008). Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. Molecular Cancer. 7(1). 19–19. 26 indexed citations

17.

Yao, Chen, Ying Lin, Mei‐Sze Chua, et al.. (2007). Interleukin‐8 modulates growth and invasiveness of estrogen receptor‐negative breast cancer cells. International Journal of Cancer. 121(9). 1949–1957. 109 indexed citations

18.

Fong, Chee Wai, Mei‐Sze Chua, Arthur B. McKie, et al.. (2006). Sprouty 2, an Inhibitor of Mitogen-Activated Protein Kinase Signaling, Is Down-Regulated in Hepatocellular Carcinoma. Cancer Research. 66(4). 2048–2058. 131 indexed citations

19.

Chua, Mei‐Sze, ST Cheung, Veronica Mason, et al.. (2006). Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Modern Pathology. 20(1). 76–83. 101 indexed citations

20.

Chua, Mei‐Sze, Christopher T. Barry, Oscar Salvatierra, & Minnie Sarwal. (2003). Molecular Profiling of Anemia in Acute Renal Allograft Rejection Using DNA Microarrays. American Journal of Transplantation. 3(1). 17–22. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact